Latest Articles
-
Does The Current Dip In Pfizer Stock Offer A Buying Opportunity?
[Updated: Feb 10, 2022] Pfizer Q4 Earnings Update The stock price of Pfizer (NYSE: PFE) has seen a fall of 8% over the last month, while it is down over 3% in a week. The recent decline can be attributed to the company’s mixed Q4 results...
-
Company Of The Day: Pfizer
What? Pfizer (NYSE:PFE) posted better than expected Q4 2021 earnings, with adjusted EPS coming in at $1.08, up from about $0.43 in Q4 2020. However, revenue growth, which came in at 104% year-over-year, missed estimates. Why? Growth was drive...
-
Forecast Of The Day: Pfizer’s Oncology Revenue
What? Pfizer’s (NYSE:PFE) Oncology Revenue, which includes revenues from Sutent, Xalkori, Inlyta, Ibrance, and other productions, rose from around $9 billion in 2019 to about $11 billion in 2020. We expect the metric to rise to around $12...
-
Will Pfizer Stock See Higher Levels After A Large 18% Rise In A Month?
[Updated: Dec 16, 2021] Pfizer Stock Rise The stock price of Pfizer (NYSE: PFE) has outperformed the broader indices. While the S&P500 index has seen a rise of 1% over the last month or so, PFE stock is up a solid 19%. This also compares wit...
-
Company Of The Day: Pfizer
What? Pfizer (NYSE:PFE) said that the third dose of its Covid-19 shot was able to neutralize the omicron variant of the novel coronavirus in lab studies. However, a two-dose regimen was much less effective at stopping the concerning new virus v...
-
Company Of The Day: Pfizer
What? Pfizer (NYSE:PFE) stock rallied to all-time highs of about $54 per share last Friday, although it fell a bit to about $52.50 on Monday. Why? The gains come amid renewed fears of another surge in Covid-19 cases as a highly mutated varian...
-
Will The Rally In Pfizer Stock Continue After A Large 21% Rise In A Month?
[Updated: Nov 18, 2021] Pfizer Stock Update The stock price of Pfizer (NYSE: PFE) has seen a rise of 21% in a month following multiple positive developments, including positive data for its oral Covid-19 treatment pill, upbeat Q3 results, and mo...
-
Will Pfizer Stock Continue To Rise?
[Updated: Nov 8, 2021] PFE Stock Rise The stock price of Pfizer (NYSE: PFE) surged 11% in a single day on Friday Nov 5, 2021. The rise can be attributed to the company announcing positive data for its oral pill for the treatment of Covid-19. Pfi...
-
Company Of The Day: Pfizer
What? The U.S. Centers for Disease Control and Prevention has formally authorized the Pfizer (NYSE:PFE) – BioNTech Covid-19 vaccine for children between the ages of 5 and 11 years old. So What? Pfizer stock remains up by about 24% year-t...
-
Is Pfizer Stock Set To See Higher Levels Post Q3 Results?
Pfizer (NYSE: PFE) is scheduled to report its Q3 2021 results on Tuesday, November 2. We expect the company to likely post revenue and earnings well above the consensus estimates, primarily led by its Covid-19 vaccine. Pfizer should see an overal...
-
A Year Since Pfizer’s Big Breakthrough, Are Vaccine Stocks Still Worth Investing In?
It’s been almost a year since Pfizer (NYSE:PFE) published incredibly strong efficacy data from its phase 3 Covid-19 vaccine trials, setting the stage for one of the largest inoculation drives in history. Our theme of Covid-19 Vaccine Stoc...
-
Here’s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month
[Updated: 9/16/2021] Pfizer Stock Decline A few weeks back, we discussed that Pfizer’s (NYSE: PFE) stock price could rebound over a one-month period after falling 4% in a week, based on its historical performance. However, PFE stock has se...
-
Company Of The Day: Pfizer
What? Pfizer’s (NYSE:PFE) Covid-19 vaccine could be available to children from ages five to eleven as soon as the end of October, per a report from Reuters. Why? Pfizer and its partner BioNTech could have sufficient data from clinical t...
-
After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?
[Updated: 8/25/2021] PFE Stock Decline The stock price of Pfizer (NYSE: PFE) reached an all-time high of $52 last week before a recent sell-off in Covid-19 vaccine stocks drove PFE down to its current level of around $48. PFE stock has fallen 4%...
-
What Are The New Developments For Pfizer’s Covid-19 Vaccine?
Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around 150,000 as of August 21, up by about 3x over the l...
